Digital Assets Report

Insight

M28 Capital ups Adagio Therapeutics holding to 8.5%

M28 Capital has acquired an additional 2.85 million share in Adagio Therapeutics (ADGI) at an average of $4.28 per share, bringing its holding to 9.2 million, according to a report by 247WallStreet. The report cites a 13D/A filing with the

Soaring eagle

Confidence soars among macro hedge funds and CTAs amid market turmoil

​​​​​​​An overwhelming majority of macro hedge funds and trend-following managers are upbeat on their performance prospects for the rest of the year – but confidence among equity-focused firms has plummeted following 2022’s stock market upheaval.

Events

14 November, 2024 – 5:00 pm

Directory Listings